Clinical Trial Update: A Two-part Study to Compare a Tablet and Capsule Formulation of GSK2838232 With and Without Food, and to Assess the Safety and Drug Levels of Repeated Once-daily Doses of GSK2838232 Without Ritonavir [Phase 1]

View source ↗

Summary

Phase 1 study comparing tablet and capsule formulations of GSK2838232 with and without food, and evaluating safety and drug levels after repeated daily doses wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Infection Human Immunodeficiency Virus

Drugs mentioned

• GSK2838232

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infection, Human Immunodeficiency Virus, HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2019-03-07